These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6684427)

  • 21. The biochemical basis of warfarin therapy.
    Suttie JW
    Adv Exp Med Biol; 1987; 214():3-16. PubMed ID: 3310547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin K-dependent carboxylase in skin.
    de Boer-van den Berg MA; Verstijnen CP; Vermeer C
    J Invest Dermatol; 1986 Sep; 87(3):377-80. PubMed ID: 3488354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for competition between vitamin K-dependent clotting factors for intracellular processing by the vitamin K-dependent gamma-carboxylase.
    Stanton C; Ross P; Hutson S; Wallin R
    Thromb Res; 1995 Oct; 80(1):63-73. PubMed ID: 8578539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The vitamin K-dependent carboxylation system in human osteosarcoma U2-OS cells. Antidotal effect of vitamin K1 and a novel mechanism for the action of warfarin.
    Wallin R; Rossi F; Loeser R; Key LL
    Biochem J; 1990 Jul; 269(2):459-64. PubMed ID: 2386486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble enzyme system for vitamin K-dependent carboxylation.
    Mack DO; Suen ET; Girardot JM; Miller JA; Delaney R; Johnson BC
    J Biol Chem; 1976 Jun; 251(11):3269-76. PubMed ID: 6448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of vitamin K and prothrombin synthesis: anticoagulants and the vitamin K--epoxide cycle.
    Bell RG
    Fed Proc; 1978 Oct; 37(12):2599-604. PubMed ID: 359368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
    Preusch PC; Suttie JW
    J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin K counteracts the effect of warfarin in liver but not in bone.
    Price PA; Kaneda Y
    Thromb Res; 1987 Apr; 46(1):121-31. PubMed ID: 3495903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Warfarin and vitamin K.
    Suttie JW
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI16-8. PubMed ID: 2191810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dose-dependent effect of warfarin on vitamin K1 metabolism and clotting factor synthesis in the rabbit.
    Park BK; Leck JB; Breckenridge AM
    Biochem Pharmacol; 1980 Jun; 29(11):1601-2. PubMed ID: 7396990
    [No Abstract]   [Full Text] [Related]  

  • 31. VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues.
    Lacombe J; Ferron M
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30050002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin K-dependent carboxylase: evidence for cofractionation of carboxylase and epoxidase activities, and for carboxylation of a high-molecular-weight microsomal protein.
    Wallin R; Suttie JW
    Arch Biochem Biophys; 1982 Mar; 214(1):155-63. PubMed ID: 7081994
    [No Abstract]   [Full Text] [Related]  

  • 33. Warfarin and the vitamin K-dependent gamma-carboxylation system.
    Wallin R; Hutson SM
    Trends Mol Med; 2004 Jul; 10(7):299-302. PubMed ID: 15242675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The biochemistry of vitamin K].
    Vermeer C
    Ned Tijdschr Geneeskd; 1985 Apr; 129(17):780-2. PubMed ID: 3873619
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.
    Ganeval D; Fischer AM; Barre J; Pertuiset N; Dautzenberg MD; Jungers P; Houin G
    Clin Nephrol; 1986 Feb; 25(2):75-80. PubMed ID: 3698349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a warfarin-sensitive serum factor that participates in factor X activation by Lewis lung tumor cells.
    Fasco MJ; Wilson AC; Lincoln D; Gierthy J
    Int J Cancer; 1987 May; 39(5):631-7. PubMed ID: 3570555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.
    Ooi QX; Wright DFB; Tait RC; Isbister GK; Duffull SB
    Clin Pharmacokinet; 2017 Dec; 56(12):1555-1566. PubMed ID: 28409488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison between vitamin K-dependent carboxylase from normal and warfarin-treated cows.
    Vermeer C; Soute BA; De Metz M; Hemker HC
    Biochim Biophys Acta; 1982 Feb; 714(2):361-5. PubMed ID: 6799008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant.
    Roncaglioni MC; Dalessandro AP; Casali B; Vermeer C; Donati MB
    Haemostasis; 1986; 16(3-4):295-9. PubMed ID: 3530904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.